explore -WSS

explore

author：knowledge 2025-10-01 12:22:23 - browse：42

A syringe injects into a segment of DNA — biotech coverage from STAT — Adobe

Two congenitally deaf children can hear for the first time after being treated with gene therapy, according to data presented at a conference Wednesday.

The results are “jaw-droppingly good, just shocking how good. It exceeded the wildest expectations of anybody who started this work,” said Larry Lustig, an otolaryngologist at Columbia University and an investigator on the study.

The new data come from a larger study by Regeneron Pharmaceuticals that will treat nearly two dozen children with a specific type of congenital hearing loss with gene therapy. The clinical trial is meant to measure safety and efficacy of DB-OTO, a gene therapy drug Regeneron is developing to treat children who have hearing loss due to changes in the otoferlin gene. Several teams are targeting this rare form of congenital deafness that affects 1% to 8% of deaf people globally, including a team with Akouos, an Eli Lilly subsidiary, which successfully treated an 11-year-old boy with a similar gene therapy. Lustig calls this the “lowest of the low-hanging fruit” for gene therapy deafness treatments.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： Georgia court denies Trump's request to quash DA's 2020 election probe

WSS

Medicare eyes cuts to doctors, raises to outpatient clinics in 2024

Medicare eyes cuts to doctors, raises to outpatient clinics in 2024

FDA seeks to regulate lab

Blood tests recalled over risk of missed heart attack diagnosis

Michigan AG announces felony charges against 'fake electors' in 2020 election plot

Why do women spend more than men on medical expenses?

explore

explore

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

leisure time

Moonlake's readout produced a cash windfall. Risks remain

J&J expands global access to TB drug amid advocacy campaign

In age of alternative facts, a scholarly course on calling out crap

STAT Virtual Event: How to Increase Diversity in Clinical Trials

Medical leaders decry Supreme Court decision on affirmative action

WHO recommends dropping component of many flu vaccines

Medicare details structure of new drug price negotiation program

Listen: Who gets the credit for GLP

Drug repurposing or repositioning? The language matters

Senator probes 340B programs at Cleveland Clinic, Bon Secours

focus

FDA advisers vote against ALS treatment from BrainStorm

Grail faces three suits alleging harassment, retaliation

Biogen shutters digital health group, ends Apple study, in cost cutting move

Eli Lilly to acquire Versanis in heated race for weight loss drugs

Does aspartame cause cancer? What new WHO guidance says

Ionis has late

focus

leisure time

entertainment

explore